Cytokine Gene Expression in a Case of B-Cell Chronic Lymphocytic Leukemia (B-CLL) With an Unusual Expansion of T Cells at Presentation

  • Athanasia Mouzaki
  • Vincent Kindler
  • Nicolette Bowers
  • Arlette Doucet
  • Maria Melachrinou
  • Maria-Christina Kyrtsonis
  • Alice Kallinikou-Maniatis

Abstract

We present a case of a 60 year old male with lymphadenopathy, hepatosplenomegaly and leucocytosis with lymphocytosis. At presentation, his WBC was 15.1x109/L with 75% lymphocytes; these were mainly T-cells with an atypical morphology, and a small monoclonal population of B cells, κ type. RT-PCR of immunoglobulin genes showed a monoclonal rearrangement of the IgM type. Elf-1, bcl-2, IL-1α and ß, IL-2, IL-4 and IL-6 genes were constitutively expressed to varying degrees, and superinduced upon mitogenic stimulation of the cells. Bandshifts with the lymphotropic transcription factors NF-kB, AP-1 and NF-AT, gave profiles typical of the T-cell leukemia Jurkat and not of normal (ex-vivo) T-cells or B-CLL cells, ex-vivo or stimulated. Bone marrow histology revealed a diffuse infiltration of lymphocytes, and immunohistochemistry on bone marrow sections the presence of both B and T-cells in almost equal proportions. At this stage a double (T/B) CLL was suspected. The patient was treated with alkylating agents and went into remission. Three months later, and while still on drugs, the patient’s WBC was found to be 5.43x109/L and immunophenotyping revealed a complete change of his T/B cell ratio. RT-PCR showed that the patient’s CD2 cells expressed none of the above genes but IL-4 when induced, and his CD19 cells IL-6 and IL-1ß when induced. The expreddion of IgM remained monoclonal, confirming the clinical observation of B leukemia development.

Keywords

Glycerol Lymphoma EDTA Leukemia Agarose 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Matthes T, Werner-Favre C, Tang H, Zhang X, Kindler V, Zubler RH: Cytokine mRNA expression during in vitro response of human B lymphocytes: Kinetics of B-cell tumor necrosis factor a, interleukin (IL)-6, IL-10 and transforming growth factor b1 mRNAs. J Exp Med 178: 521, 1993PubMedCrossRefGoogle Scholar
  2. 2.
    Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chlorophorm extraction. Anal Biochem 162: 156, 1987PubMedCrossRefGoogle Scholar
  3. 3.
    Tang H, Matthes T, Carballido-Perrig, Zubler RH, Kindler V: Differential induction of T-cell cytokine mRNA in Epstein-Barr virus-transformed B-cell clones: Constitutive and inducible expression of interleukin-4 mRNA. Eur J Immunol 23: 899, 1993PubMedCrossRefGoogle Scholar
  4. 4.
    Trainor K, Brisco MJ, Story CJ, Morley AA: Monoclonality in B-lymphoproliferative disorders detected at the DNA level. Blood 75: 2220, 1990PubMedGoogle Scholar
  5. 5.
    Shi ZR, Itzkowitz SH, Kim YS: A comparison of three immunoperoxidase techniques for antigen detection in colorectal carcinoma tissues. J Histochem Cytochem 36: 317, 1988PubMedCrossRefGoogle Scholar
  6. 6.
    Poppema S, Hollema H, Visser L, Vos H: Monoclonal antibodies (MT1, MT2, MB1, MB2, MB3) reactive with leukocyte subsets in paraffin-embedded tissue sections. Am J Pathol 127: 418, 1987PubMedGoogle Scholar
  7. 7.
    Dobson CM, Myskow MW, Krajewski AS, Carpenter FH, Horne CHW: Immunohistochemical staining of non-Hodgkin’s lymphoma in paraffin sections using MB1 and MT1 monoclonal antibodies. J Pathol 153: 203, 1987PubMedCrossRefGoogle Scholar
  8. 8.
    Kuby J (ed.): Immunology, 2nd edition, W. H. Freeman and Co., New York, 1994, p 2971Google Scholar
  9. 9.
    Ehlers S, Smith KA: Differentiation of T-cell lymphokine gene expression: The in vitro acquisition of T-cell memory. J Exp Med 173: 25, 1991PubMedCrossRefGoogle Scholar
  10. 10.
    Mouzaki A, Rungger D: Properties of transcription factors regulating interleukin 2 gene transcription through the NF-AT binding site in untreated or drug-treated naive and memory T helper cells. Blood 84: 2612, 1994PubMedGoogle Scholar
  11. 11.
    Mouzaki A, Matthes T, Miescher PA, Beris Ph: Polyclonal hypergammaglobulinaemia in a case of a B-cell Chronic Lymphocytic leukaemia: The result of IL-2 production by the proliferating monoclonal B-cells? British J Haematol (in press)Google Scholar
  12. 12.
    Mouzaki A, Serfling E, Zubler RH: Interleukin-2 promoter activity in Epstein-Barr virus-transformed B lymphocytes is controlled by nuclear factor-kB. Eur J Immunol (in press)Google Scholar
  13. 13.
    Kishimoto T (ed): Interleukins: Molecular Biology and Immunology, in: Chemical Immunology, vol. 51, Karger, Basel, 1992Google Scholar
  14. 14.
    Fujita T, Shibuya H, Ohashi T, Yamanishi K, Taniguchi T: Regulation of interleukin-2 gene: functional DNA sequences in the 5’ flanking region for the gene expression in activated T lymphocytes. Cell 46: 403, 1986CrossRefGoogle Scholar
  15. 15.
    Shaw JP, Utz PJ, Durand DB, Toole JJ, Emmel EA, Crabtree GR: Identification of a putative regulator of early T-cell activation genes. Science 241: 202, 1988PubMedCrossRefGoogle Scholar
  16. 16.
    Kindler V, Matthes T, Jeannin P, Zubler RH: IL-2 secretion by human B lymphocytes occurs as a late event and requires additional stimulation after CD40 cross-linking. Eur J Immunol 25: 1239, 1995PubMedCrossRefGoogle Scholar
  17. 17.
    Rao A: NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes. Immunology Today 15: 274, 1994PubMedCrossRefGoogle Scholar
  18. 18.
    Rooney JW, Hodge MR, McCaffrey PG, Rao A, Glimcher LH: A common factor regulates both Th1- and Th2-speciflc cytokine gene expression. EMBO J 13: 625, 1994PubMedGoogle Scholar
  19. 19.
    Yaseen NR, Maizel AL, Wang F, Sharma S: Comparative analysis of NF-AT (nuclear factor of activated T-cells) complex in human T and B lymphocytes. J Biol Chem 268: 14285, 1993PubMedGoogle Scholar
  20. 20.
    Thompson CB, Wang C-Y, Ho I-C, Bohjanen PR, Petryniak B, June CH, Miesfeldt S, Zhang L, Nabel GJ, Karpinski B, Leiden JM: cis-Acting sequences required for inducible interleukin-2 enhancer function bind a novel Ets-related protein, Elf-1. Mol Cel Biol 12: 1043, 1992Google Scholar
  21. 21.
    Liou H-C, Baltimore D: Regulation of the NF-kB/rel transcription factor and IkB inhibitor system. Current Opinion in Cell Biol 5: 477, 1993.CrossRefGoogle Scholar
  22. 22.
    Northorp JP, Ho SN, Chen l, Thomas DJ, Timmerman LA, Nolan GP, Admon A, Crabtree GR: NF-AT components define a family of transcription factors targeted in T-cell activation. Nature 369: 497, 1994CrossRefGoogle Scholar
  23. 23.
    Rai KR, Patel DV: Chronic lymphocytic leukemia, in Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE (eds): Hematology, basic principles and practice, New York, Churchill Livingstone, 1995Google Scholar
  24. 24.
    John S, Reeves RB, Lin JX, Child R, Leiden JM, Thompson CB, Leonard WJ: Regulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y) and NF-kappa B family proteins. Mol Cell Biol 15: 1786, 199Google Scholar
  25. 25.
    Nolan GP: NF-AT-AP-1 and Rel-bZIP: Hybrid vigor and binding under the influence. Cell 77: 795, 1994PubMedCrossRefGoogle Scholar
  26. 26.
    Vaux DL, Cory S, Adams JM: Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B-cells. Nature 335: 440, 1988PubMedCrossRefGoogle Scholar
  27. 27.
    Thompson CB, Brown TA, McKnight SL: Convergence of ETS- and notch-related structural motifs in a heteromeric DNA binding complex. Science 253: 762, 1991PubMedCrossRefGoogle Scholar
  28. 28.
    Kang S-M, Beverley B, Tran A-C, Brorson K, Schwartz RH, Lenardo MJ: Transactivation by AP-1 is a molecular target of T-cell clonal anergy. Science 257: 1134, 1992PubMedCrossRefGoogle Scholar
  29. 29.
    Zaknoen SL, Christian SL, Suen R, Van Ness B, Kay NE: B-chronic lymphocytic leukemia cells contain both endogenous k immunoglobulin mRNA and critical immunoglobulin gene activation transcription factors. Leukemia 6: 675, 1992PubMedGoogle Scholar
  30. 30.
    Baltimore D, Beg AA: A butterfly flutters by. Nature 373: 287, 1995PubMedCrossRefGoogle Scholar
  31. 31.
    Hanada M, Delia D, Aiello A, Stadtmauer E, Reed JC: bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 6: 1820, 1993Google Scholar
  32. 32.
    Raziuddin S, Sheikha A, Abu-Eshy S, Al-Janadi M: Circulating levels of cytokines and soluble cytokine receptors in various T-cell malignancies. CANCER 73: 2426, 1994PubMedCrossRefGoogle Scholar
  33. 33.
    Rambaldi A, Bettoni S, Rossi V, Tini M-L, Giudici G, Rizzo V, Bassan R, Mantovani A, Barbui T, Biondi A: Transcripitonal and post-transcriptional regulation of IL-lb, IL-6 and TNF-a genes in chronic lymphocytic leukaemia. Br J Haematol 83: 204, 1993PubMedCrossRefGoogle Scholar
  34. 34.
    Mouzaki A, Rungger D: Interleukin 2 gene regulation at the Pud (NF-AT) promoter element: The complex situation in primary T lymphocytes. Molecular Biology of Hematopoiesis 3: 475, 1994Google Scholar
  35. 35.
    Harland CC, Whittaker SJ, NG YL, Holden CA, Wong E, Smith NP: Coexistent cutaneous T-cell lymphoma and B-cell chronic lymphocytic leukemia. Br J Dermatol 127: 519, 1992PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1996

Authors and Affiliations

  • Athanasia Mouzaki
    • 1
    • 2
    • 4
  • Vincent Kindler
    • 2
  • Nicolette Bowers
    • 2
  • Arlette Doucet
    • 2
  • Maria Melachrinou
    • 3
  • Maria-Christina Kyrtsonis
    • 1
  • Alice Kallinikou-Maniatis
    • 1
  1. 1.Hematology LaboratoryPatras University HospitalGreece
  2. 2.Division of HematologyGeneva University HospitalSwitzerland
  3. 3.Pathology LaboratoryPatras University HospitalGreece
  4. 4.Laboratory Hematology and Transfusion Medicine, Medical SchoolUniversity HospitalGreece

Personalised recommendations